Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth

Merck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.